Our focus areas

Unlocking the power of what science can do

The path to new treatments

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Cardiovascular and Metabolic diseases; Oncology; Respiratory, Inflammation and Autoimmunity; Infection and Neuroscience.

   

An exciting pipeline

Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

146

projects in our pipeline

2

new molecular entity approvals in the last quarter

15

new molecular entities in our late-stage pipeline